Prognostic Implications of Creatine Kinase Elevation After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

This publication has 32 references indexed in Scilit:

• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
  The Lancet, 2003
• Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction
  JACC, 2000
• Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction∗∗A complete list of the TAMI Study Group appears in J Am Coll Cardiol 1992;19:482–489.
  The American Journal of Cardiology, 2000
• Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty
  The American Journal of Cardiology, 1999
• Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction
  The American Journal of Cardiology, 1987
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Comparison of enzymatic and anatomic estimates of myocardial infarct size in man.
  Circulation, 1984
• Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction.
  Circulation, 1979
• Estimation of Infarct Size in Man and its Relation to Prognosis
  Circulation, 1972
• The use of biplane angiocardiography for the measurement of left ventricular volume in man
  American Heart Journal, 1960